Yes GLP-1 receptor agonists like semaglutide and tirzepatide do not share monoamine transporter targets with tesofensine, making this combination low-risk
Randomisation in these trials was stratified by baseline background medication
They will monitor your response metrics and may recommend genetic testing through the Precision Peptide Genetic Test ($298) to ensure your current treatment aligns with your GIPR, and metabolic gene variants
Hjuler K F, Brgger-Mikkelsen M, Pedersen S, et al
Zepbound vials, a more affordable alternative, are now available directly from Eli Lilly and Ro (yes, Ro!)
Interest in long-term contraception : Your provider can discuss whether transitioning to a LARC might offer both convenience and certainty